<DOC>
	<DOC>NCT01364441</DOC>
	<brief_summary>The primary objective of this study is to evaluate the safety and tolerability of ONO-2952 across ascending single doses in healthy adult male and female subjects. The secondary objective is to characterize the pharmacokinetic (PK) profile of ONO-2952. The tertiary objective of this study is to preliminarily evaluate the effect of a meal upon the PK profile of ONO-2952.</brief_summary>
	<brief_title>Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking male or female subjects (1855 inclusive) Body mass index (BMI) of 1935 kg/m2 (inclusive) For females, surgically sterilized, postmenopausal, or who are non lactating and agree to use a double barrier method of contraception History or presence of clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-2950</keyword>
	<keyword>healthy adult subjects</keyword>
	<keyword>first in human</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>